BAK1 and pancreatic neoplasm: Compared with those from the normal controls, immunohistochemical results from the pancreatic tissues revealed statistical increases in the expression of BAK1, ITGA3, BAG3, and APOL1 in pancreatic cancer patients; no immunohistochemical data were available for RAB24 (Fig. 9D).